Konsensusempfehlung zur Auswahl von Wirkstoffen für die Wundantiseptik

Wundmanagement Switzerland Embrach/Zurich (CH) 3) Andriessen Consultants, Malden (NL), Thames Valley University, London (GB) 4) Inst. fur Hygiene und Mikrobiologie am Zentralklinikum St. Polten (A) 5) Institute for Medical Outcome Research GmbH Lorrach (D) 6) Bundeswehrkrankenhaus Ulm, Abteilung II, Chirurgie (D) 7) Chir. Klinik I Allgemeinund Viszeralchirurgie, St. Marien-Hospital Lunen (D) 8) Inst. fur Med. Mikrobiologie und Krankenhaushygiene der Universitat Tubingen (D) 9) Klinik und Poliklinik fur Hautkrankheiten der Universitat Greifswald (D) 10) Pathologisches Institut Humaine-Klinikum Bad Saarow (D) 11) Inst. fur Med. Mikrobiologie der Universitat Magdeburg (D) 12) Abt. fur Unfallund Wiederherstellungschirurgie der Klinik fur Chirurgie der

[1]  A. Kramer,et al.  A standardized test to assess the impact of different organic challenges on the antimicrobial activity of antiseptics. , 2003, The Journal of hospital infection.

[2]  A. Kramer,et al.  In vitro action of combinations of selected antimicrobial agents and adult bovine articular cartilage (sesamoid bone). , 2003, Chemico-biological interactions.

[3]  A. Kramer,et al.  Antibacterial activity and endotoxin-binding capacity of Actisorb Silver 220. , 2003, The Journal of hospital infection.

[4]  R. Sherman,et al.  Maggot therapy for treating diabetic foot ulcers unresponsive to conventional therapy. , 2003, Diabetes care.

[5]  D. Fassler,et al.  Biosurgery supports granulation and debridement in chronic wounds – clinical data and remittance spectroscopy measurement , 2002, International journal of dermatology.

[6]  J. Dissemond,et al.  Therapie eines Methicillin-resistenten Staphylococcus aureus (MRSA) im Rahmen der Behandlung eines chronischen Ulkus mittels Biochirurgie , 2002, Der Hautarzt.

[7]  A. Kramer,et al.  Efficacy and tolerance of selected antiseptic substances in respect of suitability for use on the eye. , 2002, Developments in ophthalmology.

[8]  R. Sherman.  Maggot versus conservative debridement therapy for the treatment of pressure ulcers , 2002, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[9]  J. Daróczy.  Antiseptic Efficacy of Local Disinfecting Povidone-Iodine (Betadine®) Therapy in Chronic Wounds of Lymphedematous Patients , 2002, Dermatology.

[10]  J. Perrot,et al.  [Increased serum and urinary levels of silver during treatment with topical silver sulfadiazine]. , 2002, Annales de dermatologie et de venereologie.

[11]  E. Wolf,et al.  Reaktion des hyalinen Gelenkknorpels und der Synovialis auf eine intraartikuläre Instillation von verschiedenen Antiinfektiva , 2001, Arthroskopie.

[12]  D. Bonn.  Maggot therapy: an alternative for wound infection , 2000, The Lancet.

[13]  V. Falanga.  Classifications for wound bed preparation and stimulation of chronic wounds , 2000, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[14]  J. Wayman,et al.  The cost effectiveness of larval therapy in venous ulcers. , 2000, Journal of tissue viability.

[15]  P. Vogt,et al.  An Innovative Topical Drug Formulation for Wound Healing and Infection Treatment: In vitro and in vivo Investigations of a Povidone-Iodine Liposome Hydrogel , 2000, Dermatology.

[16]  P. Wutzler,et al.  Virucidal and Chlamydicidal Activities of Eye Drops with Povidone-Iodine Liposome Complex , 2000, Ophthalmic Research.

[17]  T. Ryan,et al.  Larva therapy in wound management , 2000, Journal of the Royal Society of Medicine.

[18]  J. Stessman,et al.  Maggot therapy for the treatment of intractable wounds , 1999, International journal of dermatology.

[19]  A. Kawada,et al.  Contact sensitivity induced by neomycin with cross‐sensitivity to other aminoglycoside antibiotics , 1998, Contact dermatitis.

[20]  A. Kramer,et al.  Explantationstest mit Haut und Peritoneum der neonatalen Ratte als Voraussagetest zur Verträglichkeit lokaler Antiinfektiva für Wunden und Körperhöhlen , 1998, Der Chirurg.

[21]  W. König,et al.  Effects of Betaisodona on parameters of host defense. , 1997, Dermatology.

[22]  P. Prete,et al.  Growth effects of Phaenicia sericata larval extracts on fibroblasts: mechanism for wound healing by maggot therapy. , 1997, Life sciences.

[23]  W. van Oeveren,et al.  Effect of intraperitoneal antimicrobials on the concentration of bacteria, endotoxin, and tumor necrosis factor in abdominal fluid and plasma in rats. , 1996, European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes.

[24]  S. Willatts,et al.  Effect of the antiendotoxic agent, taurolidine, in the treatment of sepsis syndrome: a placebo-controlled, double-blind trial. , 1995, Critical care medicine.

[25]  R. Reding,et al.  Taurolidine peritoneal lavage as prophylaxis against infection after elective colorectal surgery , 1995, The British journal of surgery.

[26]  A. D. Russell,et al.  Antibacterial activity of Actisorb Plus, Actisorb and silver nitrate. , 1994, The Journal of hospital infection.

[27]  D. Herndon,et al.  Cytoprotection of human dermal fibroblasts against silver sulfadiazine using recombinant growth factors. , 1994, The Journal of surgical research.

[28]  W. Traub,et al.  Taurolidine: in vitro activity against multiple-antibiotic-resistant, nosocomially significant clinical isolates of Staphylococcus aureus, Enterococcus faecium, and diverse Enterobacteriaceae. , 1993, Chemotherapy.

[29]  I. Bedrosian,et al.  Taurolidine, an analogue of the amino acid taurine, suppresses interleukin 1 and tumor necrosis factor synthesis in human peripheral blood mononuclear cells. , 1991, Cytokine.

[30]  R. Skurray,et al.  Antimicrobial resistance of Staphylococcus aureus: genetic basis , 1987, Microbiological reviews.

[31]  T. Ikeda,et al.  Interaction of biologically active molecules with phospholipid membranes. I. Fluorescence depolarization studies on the effect of polymeric biocide bearing biguanide groups in the main chain. , 1983, Biochimica et biophysica acta.

[32]  L. Gershenfeld.  Povidone-iodine as a sporicide. , 1962, American journal of pharmacy and the sciences supporting public health.

[33]  E. A. Wright,et al.  An Antibiotic from Maggots , 1957, Nature.

[34]  A. Billing,et al.  Der einfluß von taurolin auf die körpereigene Abwehr und die keimelimination bei der menschlichen peritonitis , 2004, Langenbecks Archiv für Chirurgie.

[35]  H. Kock,et al.  Wirksamkeit eines neuartigen Antisepticum in der Behandlung kontaminierter Weichteilwunden , 2001, Der Chirurg.

[36]  J. Hara,et al.  Preoperative disinfection of the conjunctival sac in cataract surgery. , 1997, Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde.

[37]  A. Kramer,et al.  Prophylactic use of topical anti-infectives in ophthalmology. , 1997, Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde.

[38]  F. Wyle,et al.  Maggot therapy for treating pressure ulcers in spinal cord injury patients. , 1995, The journal of spinal cord medicine.

[39]  J. Hansbrough,et al.  Cytotoxicity to human leukocytes by topical antimicrobial agents used for burn care. , 1993, The Journal of burn care & rehabilitation.

[40]  R. Kreis,et al.  A comparative burn wound model in the New Yorkshire pig for the histopathological evaluation of local therapeutic regimens: silver sulfadiazine cream as a standard. , 1993, British journal of plastic surgery.

[41]  V. Hingst,et al.  Antiseptische Sanierung von Staphylococcus aureus — Keimträgern in der Nase , 1993 .

[42]  G. Hierholzer,et al.  PVP-Jod in der operativen Medizin , 1984 .

[43]  W. Konig,et al.  JOB - DIE STELLUNG EINES ALTEN DESINFEKTIONSMITTELS IN DER MODERNEN INFEKTIOLOGIE , 1977 .